A Study to Evaluate the Safety and Efficacy of Zoledronic Acid in the Prevention or Delaying of Bone Metastasis in Patients With Stage IIIA and IIIB Non-small Cell Lung Cancer (NSCLC)
Clinical trial NCT00172042 · COMPLETED
Trial details
- NCT number
- NCT00172042
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2005-03-01
- Primary completion
- 2010-05-01
- Enrollment
- 437
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.